BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15805285)

  • 1. Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration.
    Lee BC; Lee TH; Zagozdzon R; Avraham S; Usheva A; Avraham HK
    Cancer Res; 2005 Apr; 65(7):2840-5. PubMed ID: 15805285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional down-regulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells.
    Hasegawa A; Yasukawa M; Sakai I; Fujita S
    J Immunol; 2001 Jan; 166(2):1125-31. PubMed ID: 11145693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry.
    Moriuchi M; Moriuchi H; Margolis DM; Fauci AS
    J Immunol; 1999 May; 162(10):5986-92. PubMed ID: 10229837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Csk homologous kinase inhibits CXCL12-CXCR4 signaling in neuroblastoma.
    Zagozdzon R; Fu Y; Avraham HK
    Int J Oncol; 2008 Mar; 32(3):619-23. PubMed ID: 18292939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
    McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
    Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc.
    Austen M; Cerni C; Lüscher-Firzlaff JM; Lüscher B
    Oncogene; 1998 Jul; 17(4):511-20. PubMed ID: 9696045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
    Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
    Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.
    Kulbe H; Hagemann T; Szlosarek PW; Balkwill FR; Wilson JL
    Cancer Res; 2005 Nov; 65(22):10355-62. PubMed ID: 16288025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
    Lee BC; Lee TH; Avraham S; Avraham HK
    Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
    Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
    Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YY1 transcription factor is not responsible for the negative regulation of hamster Muc1 transcription.
    Hisatsune A; Hyun SW; Lee IJ; Georas S; Kim KC
    Anticancer Res; 2004; 24(1):235-40. PubMed ID: 15015602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.
    de Nigris F; Botti C; Rossiello R; Crimi E; Sica V; Napoli C
    Oncogene; 2007 Jan; 26(3):382-94. PubMed ID: 16878156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
    Sutton A; Friand V; Brulé-Donneger S; Chaigneau T; Ziol M; Sainte-Catherine O; Poiré A; Saffar L; Kraemer M; Vassy J; Nahon P; Salzmann JL; Gattegno L; Charnaux N
    Mol Cancer Res; 2007 Jan; 5(1):21-33. PubMed ID: 17259344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z; Ge L; Wang M; Carr BI
    J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells.
    Zagozdzon R; Bougeret C; Fu Y; Avraham HK
    Int J Oncol; 2002 Dec; 21(6):1347-52. PubMed ID: 12429987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHK down-regulates SCF/KL-activated Lyn kinase activity in Mo7e megakaryocytic cells.
    Price DJ; Rivnay B; Avraham H
    Biochem Biophys Res Commun; 1999 Jun; 259(3):611-6. PubMed ID: 10364466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
    Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
    Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells.
    Holland JD; Kochetkova M; Akekawatchai C; Dottore M; Lopez A; McColl SR
    Cancer Res; 2006 Apr; 66(8):4117-24. PubMed ID: 16618732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.